
Role and Importance of Inflammasomes and Immune Pathways in Myeloid Malignancies, Particularly Myelodysplastic Syndromes (MDS)/Acute Myeloid Leukemia (AML) to Better Understand the Disease Pathophysiology and Decipher the Scope of Therapeutic Interventions
Author(s) -
Ricardo Gobato,
Abhijit Mitra
Publication year - 2021
Publication title -
open journal of radiology and medical imaging
Language(s) - English
Resource type - Journals
ISSN - 2583-1534
DOI - 10.36811/ojrmi.2021.110040
Subject(s) - medicine , myeloid leukemia , cancer , myelodysplastic syndromes , disease , myeloid , inflammation , melanoma , myeloid cells , immune system , cancer research , immunology , bone marrow
Thanks to work by researchers at the California South University (CSU) Cancer Research Institute (CRI), they may soon have new tools to treat melanoma and other cancers. In an article published last month, members of the Cancer Research Institute (CRI) introduced an intracellular complex. Involved in melanoma-mediated inflammation and leads to tumor growth and progression. The researchers found that by inhibiting NLRP3, they could reduce inflammation and tumor spread.Keywords: Cancer; Cells; Tissues; Tumors; Prevention; Prognosis; Diagnosis; Imaging; Screening, Treatment; Management